Young adults diagnosed with Hodgkin lymphoma are at risk of relapsing late: a comprehensive analysis of late relapse in Hodgkin lymphoma

[1]  F. Magyari,et al.  Employment status and health related quality of life among Hodgkin-lymphoma survivors’– results based on data from a major treatment center in Hungary , 2017, Health and Quality of Life Outcomes.

[2]  W. Ludwig,et al.  Late Relapse of Classical Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group HD7 to HD12 Trials. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  F. Magyari,et al.  How the Epidemiology of Hodgkin Lymphoma Changed in Debrecen, Hungary , 2016 .

[4]  M. Bøgsted,et al.  No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish‐Swedish population‐based observational study , 2016, British journal of haematology.

[5]  M. Shima,et al.  Relevant role of von Willebrand factor in neutrophil recruitment in a mouse sepsis model involving cecal ligation and puncture , 2016, Haematologica.

[6]  T. Springer,et al.  Cytoskeletal perturbation leads to platelet dysfunction and thrombocytopenia in variant forms of Glanzmann thrombasthenia , 2016, Haematologica.

[7]  G. Bonadonna,et al.  Late Relapse in Hodgkin Lymphoma (HL): A Retrospective Analysis of Patients Enrolled on Clinical Trials at the Istituto Nazionale Tumori of Milan (INT-MI) , 2015 .

[8]  A. Stamatoullas,et al.  Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study , 2015, Haematologica.

[9]  Rachel Bar-Shalom,et al.  Hodgkin lymphoma patients in first remission: routine positron emission tomography/computerized tomography imaging is not superior to clinical follow‐up for patients with no residual mass , 2014, British journal of haematology.

[10]  H. Johnsen,et al.  Positron emission tomography/computed tomography surveillance in patients with Hodgkin lymphoma in first remission has a low positive predictive value and high costs , 2012, Haematologica.

[11]  J. Friedberg,et al.  Late relapses following high-dose autologous stem cell transplantation (HD-ASCT) for Hodgkin's lymphoma (HL) in the ABVD therapeutic era. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[12]  R. Russell,et al.  Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment , 2011, Current cardiology reviews.

[13]  V. Pavone,et al.  Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas , 2010, Advances in hematology.

[14]  M. Provencio,et al.  Late relapses in Hodgkin lymphoma: a clinical and immunohistochemistry study , 2010, Leukemia & lymphoma.

[15]  M. Ellis,et al.  Late relapse of Hodgkin's lymphoma presenting as fatal hematemesis caused by an esophago-tracheo-arterial fistula. , 2009, The Israel Medical Association journal : IMAJ.

[16]  C. Bloomfield,et al.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. , 2009, Blood.

[17]  M. Deutsch,et al.  Very Late Relapse of Hodgkin’s Disease: A Report of Five Patients , 2001, American journal of clinical oncology.

[18]  G Flandrin,et al.  The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  L. Paz-Ares,et al.  Favorable prognosis after late relapse of hodgkin's disease , 1998, Cancer.

[20]  J. Brierley,et al.  Late relapse after treatment for clinical Stage I and II Hodgkin's disease , 1997, Cancer.

[21]  P. Brousset,et al.  Persistence of the same viral strain in early and late relapses of Epstein-Barr virus-associated Hodgkin's disease. , 1994, Blood.

[22]  E. Noordijk,et al.  Late relapse in early-stage Hodgkin's disease patients enrolled on European Organization for Research and Treatment of Cancer protocols. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  F. Gherlinzoni,et al.  "Very late" relapses in Hodgkin's disease patients: a rare but real phenomenon. , 1992, Haematologica.

[24]  M Tubiana,et al.  Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  M Tubiana,et al.  Report of the Committee on Hodgkin's Disease Staging Classification. , 1971, Cancer research.

[26]  L. Craver,et al.  Report of the Nomenclature Committee , 1966 .

[27]  O. Markovic,et al.  Late relapse of Hodgkin's lymphoma - is it different in clinical characteristics and outcome? , 2017, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[28]  A. Schuh,et al.  PRESENCE OF MULTIPLE UNMUTATED IGHV REARRANGEMENTS IN CLL PATIENTS IS ASSOCIATED WITH A VERY SHORT TREATMENT- FREE SURVIVAL: RESULTS FROM 2 INDEPENDENT COHORTS , 2016 .

[29]  B. Mihaljević,et al.  Hodgkin’s lymphoma relapse in the uterine cervix 15 years after the initial cure , 2008, Medical oncology.

[30]  C. Bloomfield,et al.  World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  R. Siebert,et al.  Recurrence of Hodgkin's disease after 10 or more years: late relapse or de-novo malignancy due to HLA-DPB1*0301-linked susceptibility? , 1997, Leukemia & lymphoma.

[32]  M. Spittle,et al.  Hodgkin's disease: a case of late relapse. , 1993, Clinical oncology (Royal College of Radiologists (Great Britain)).

[33]  W. Balwierz,et al.  Relapse of Hodgkin's Disease After Ten Years , 1992 .

[34]  D. Wright,et al.  Late recurrence in Hodgkin's disease: a report of two cases. , 1984, Medical and pediatric oncology.